The Exchange had sought clarification from Global Health Limited for the quarter ended 31-Mar-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: -1. The company has not submitted declaration in case of unmodified opinion(s) The response of the Company is enclosed.
MEDANTA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The NSE sought clarification from Global Health Limited regarding Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, for the quarter ended 31-March-2025. The exchange pointed out that the company had not submitted the mandatory declaration in case of unmodified audit opinion(s). The company has now submitted its response to the exchange to address this compliance gap.
This is largely a routine regulatory compliance matter and does not indicate any financial irregularity. Shareholders should note it as a minor disclosure lapse that has now been addressed, with no expected material impact on the stock price.